Literature DB >> 24778229

A rifamycin inactivating phosphotransferase family shared by environmental and pathogenic bacteria.

Peter Spanogiannopoulos1, Nicholas Waglechner1, Kalinka Koteva1, Gerard D Wright2.   

Abstract

Many environmental bacteria are multidrug-resistant and represent a reservoir of ancient antibiotic resistance determinants, which have been linked to genes found in pathogens. Exploring the environmental antibiotic resistome, therefore, reveals the diversity and evolution of antibiotic resistance and also provides insight into the vulnerability of clinically used antibiotics. In this study, we describe the identification of a highly conserved regulatory motif, the rifampin (RIF) -associated element (RAE), which is found upstream of genes encoding RIF-inactivating enzymes from a diverse collection of actinomycetes. Using gene expression assays, we confirmed that the RAE is involved in RIF-responsive regulation. By using the RAE as a probe for new RIF-associated genes in several actinomycete genomes, we identified a heretofore unknown RIF resistance gene, RIF phosphotransferase (rph). The RPH enzyme is a RIF-inactivating phosphotransferase and represents a new protein family in antibiotic resistance. RPH orthologs are widespread and found in RIF-sensitive bacteria, including Bacillus cereus and the pathogen Listeria monocytogenes. Heterologous expression and in vitro enzyme assays with purified RPHs from diverse bacterial genera show that these enzymes are capable of conferring high-level resistance to a variety of clinically used rifamycin antibiotics. This work identifies a new antibiotic resistance protein family and reinforces the fact that the study of resistance in environmental organisms can serve to identify resistance elements with relevance to pathogens.

Entities:  

Keywords:  drug inactivation; gene regulation; phosphorylation; silent resistome

Mesh:

Substances:

Year:  2014        PMID: 24778229      PMCID: PMC4024899          DOI: 10.1073/pnas.1402358111

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  45 in total

Review 1.  Molecular genetic basis of antimicrobial agent resistance in Mycobacterium tuberculosis: 1998 update.

Authors:  S Ramaswamy; J M Musser
Journal:  Tuber Lung Dis       Date:  1998

2.  CDART: protein homology by domain architecture.

Authors:  Lewis Y Geer; Michael Domrachev; David J Lipman; Stephen H Bryant
Journal:  Genome Res       Date:  2002-10       Impact factor: 9.043

3.  Wide variation in antibiotic resistance proteins identified by functional metagenomic screening of a soil DNA library.

Authors:  Kelly M McGarvey; Konstantin Queitsch; Stanley Fields
Journal:  Appl Environ Microbiol       Date:  2012-01-13       Impact factor: 4.792

4.  D-Ala-D-Ala ligases from glycopeptide antibiotic-producing organisms are highly homologous to the enterococcal vancomycin-resistance ligases VanA and VanB.

Authors:  C G Marshall; G Broadhead; B K Leskiw; G D Wright
Journal:  Proc Natl Acad Sci U S A       Date:  1997-06-10       Impact factor: 11.205

5.  The mechanism of the phosphoenolpyruvate synthase reaction.

Authors:  R A Cooper; H L Kornberg
Journal:  Biochim Biophys Acta       Date:  1967-06-13

Review 6.  Rifaximin--a novel antimicrobial for enteric infections.

Authors:  David B Huang; Herbert L DuPont
Journal:  J Infect       Date:  2005-02       Impact factor: 6.072

Review 7.  Rifamycins--obstacles and opportunities.

Authors:  Paul A Aristoff; George A Garcia; Paul D Kirchhoff; H D Showalter
Journal:  Tuberculosis (Edinb)       Date:  2010-03-16       Impact factor: 3.131

Review 8.  Rifalazil and other benzoxazinorifamycins in the treatment of chlamydia-based persistent infections.

Authors:  David M Rothstein; John van Duzer; Andrew Sternlicht; Steven C Gilman
Journal:  Arch Pharm (Weinheim)       Date:  2007-10       Impact factor: 3.751

9.  Chloramphenicol induction of cat-86 requires ribosome stalling at a specific site in the leader.

Authors:  Z Alexieva; E J Duvall; N P Ambulos; U J Kim; P S Lovett
Journal:  Proc Natl Acad Sci U S A       Date:  1988-05       Impact factor: 11.205

10.  CDD: conserved domains and protein three-dimensional structure.

Authors:  Aron Marchler-Bauer; Chanjuan Zheng; Farideh Chitsaz; Myra K Derbyshire; Lewis Y Geer; Renata C Geer; Noreen R Gonzales; Marc Gwadz; David I Hurwitz; Christopher J Lanczycki; Fu Lu; Shennan Lu; Gabriele H Marchler; James S Song; Narmada Thanki; Roxanne A Yamashita; Dachuan Zhang; Stephen H Bryant
Journal:  Nucleic Acids Res       Date:  2012-11-28       Impact factor: 16.971

View more
  19 in total

Review 1.  Molecular mechanisms of antibiotic resistance.

Authors:  Jessica M A Blair; Mark A Webber; Alison J Baylay; David O Ogbolu; Laura J V Piddock
Journal:  Nat Rev Microbiol       Date:  2014-12-01       Impact factor: 60.633

Review 2.  What is a resistance gene? Ranking risk in resistomes.

Authors:  José L Martínez; Teresa M Coque; Fernando Baquero
Journal:  Nat Rev Microbiol       Date:  2014-12-15       Impact factor: 60.633

3.  The complex resistomes of Paenibacillaceae reflect diverse antibiotic chemical ecologies.

Authors:  Andrew C Pawlowski; Erin L Westman; Kalinka Koteva; Nicholas Waglechner; Gerard D Wright
Journal:  ISME J       Date:  2017-12-19       Impact factor: 10.302

Review 4.  Repositioning rifamycins for Mycobacterium abscessus lung disease.

Authors:  Uday S Ganapathy; Véronique Dartois; Thomas Dick
Journal:  Expert Opin Drug Discov       Date:  2019-06-14       Impact factor: 6.098

5.  Arr-cb Is a Rifampin Resistance Determinant Found Active or Cryptic in Clostridium bolteae Strains.

Authors:  Jean-Christophe Marvaud; Thierry Lambert
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

Review 6.  Comparison of Antibiotic Resistance Mechanisms in Antibiotic-Producing and Pathogenic Bacteria.

Authors:  Hiroshi Ogawara
Journal:  Molecules       Date:  2019-09-21       Impact factor: 4.411

7.  The Structure of the Antibiotic Deactivating, N-hydroxylating Rifampicin Monooxygenase.

Authors:  Li-Kai Liu; Heba Abdelwahab; Julia S Martin Del Campo; Ritcha Mehra-Chaudhary; Pablo Sobrado; John J Tanner
Journal:  J Biol Chem       Date:  2016-08-24       Impact factor: 5.157

8.  Insight rifampicin-resistant (rpoB) mutation in Pseudomonas stutzeri leads to enhance the biosynthesis of secondary metabolites to survive against harsh environments.

Authors:  Khandakar Mohiul Alam; Yongliang Yan; Min Lin; Md Ariful Islam; Ahmed Gaber; Akbar Hossain
Journal:  Arch Microbiol       Date:  2022-06-29       Impact factor: 2.552

9.  Structural basis of rifampin inactivation by rifampin phosphotransferase.

Authors:  Xiaofeng Qi; Wei Lin; Miaolian Ma; Chengyuan Wang; Yang He; Nisha He; Jing Gao; Hu Zhou; Youli Xiao; Yong Wang; Peng Zhang
Journal:  Proc Natl Acad Sci U S A       Date:  2016-03-21       Impact factor: 11.205

Review 10.  Next-generation approaches to understand and combat the antibiotic resistome.

Authors:  Terence S Crofts; Andrew J Gasparrini; Gautam Dantas
Journal:  Nat Rev Microbiol       Date:  2017-04-10       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.